A detailed history of Voya Investment Management LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 21,245 shares of ORIC stock, worth $220,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,245
Previous 13,029 63.06%
Holding current value
$220,098
Previous $179,000 16.2%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.63 - $12.93 $54,472 - $106,232
8,216 Added 63.06%
21,245 $150,000
Q1 2024

May 15, 2024

SELL
$8.04 - $16.03 $27,561 - $54,950
-3,428 Reduced 20.83%
13,029 $179,000
Q4 2023

Feb 14, 2024

BUY
$5.41 - $9.43 $2,845 - $4,960
526 Added 3.3%
16,457 $151,000
Q2 2023

Aug 14, 2023

BUY
$4.95 - $8.4 $78,858 - $133,820
15,931 New
15,931 $123,000
Q2 2022

Aug 15, 2022

SELL
$2.7 - $7.07 $32,278 - $84,521
-11,955 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$4.54 - $16.1 $250,780 - $889,331
-55,238 Reduced 82.21%
11,955 $64,000
Q4 2021

Feb 14, 2022

SELL
$12.01 - $20.3 $1.4 Million - $2.36 Million
-116,319 Reduced 63.38%
67,193 $987,000
Q3 2021

Nov 15, 2021

BUY
$15.9 - $25.22 $484,329 - $768,226
30,461 Added 19.9%
183,512 $3.84 Million
Q2 2021

Aug 16, 2021

BUY
$17.37 - $25.34 $913,140 - $1.33 Million
52,570 Added 52.32%
153,051 $2.71 Million
Q1 2021

May 17, 2021

BUY
$23.67 - $36.85 $77,803 - $121,125
3,287 Added 3.38%
100,481 $2.46 Million
Q4 2020

Feb 16, 2021

BUY
$20.32 - $39.8 $1.97 Million - $3.87 Million
97,194 New
97,194 $3.29 Million

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $410M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.